Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedApr 18, 2024
DataAggregated Company Financials
Companies6
  • 7D-1.6%
  • 3M5.3%
  • 1Y-5.5%
  • YTD5.7%

Over the last 7 days, the Pharma industry has dropped 2.0%, driven by declines from every company within the industry. Overall the industry is down 8.1% in 12 months. As for the next few years, earnings are forecast to decline by 19% per annum.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 18 Apr 2024RM4.5bRM2.6bRM559.3m12.2x8x1.7x
Sat, 16 Mar 2024RM4.5bRM2.6bRM559.3m12.3x8.1x1.7x
Mon, 12 Feb 2024RM4.6bRM2.6bRM584.9m12.2x7.8x1.8x
Wed, 10 Jan 2024RM4.4bRM2.6bRM584.9m12.5x7.5x1.7x
Fri, 08 Dec 2023RM4.1bRM2.6bRM584.9m12.2x7.1x1.6x
Sun, 05 Nov 2023RM4.2bRM2.6bRM604.4m11.9x6.9x1.6x
Tue, 03 Oct 2023RM4.3bRM2.6bRM604.4m12.5x7.1x1.7x
Thu, 31 Aug 2023RM4.3bRM2.6bRM604.6m12.6x7.1x1.7x
Sat, 29 Jul 2023RM4.4bRM2.6bRM304.7m14.2x14.4x1.7x
Mon, 26 Jun 2023RM4.3bRM2.6bRM304.7m14.6x14.2x1.7x
Wed, 24 May 2023RM4.8bRM2.5bRM291.8m13.5x16.4x1.9x
Fri, 21 Apr 2023RM4.7bRM2.5bRM289.8m13.4x16.4x1.9x
Sun, 19 Mar 2023RM4.6bRM2.5bRM289.8m13.3x15.9x1.8x
Tue, 14 Feb 2023RM4.6bRM2.4bRM270.7m13.2x16.9x1.9x
Thu, 12 Jan 2023RM4.7bRM2.4bRM270.7m12.9x17.5x1.9x
Sat, 10 Dec 2022RM4.5bRM2.4bRM270.7m12.2x16.5x1.8x
Mon, 07 Nov 2022RM4.1bRM2.4bRM249.0m12.3x16.3x1.7x
Wed, 05 Oct 2022RM3.7bRM2.4bRM249.0m11.5x15x1.6x
Fri, 02 Sep 2022RM3.9bRM2.4bRM249.0m11.8x15.5x1.6x
Sun, 31 Jul 2022RM4.0bRM2.3bRM226.0m13.8x17.6x1.7x
Tue, 28 Jun 2022RM3.5bRM2.3bRM226.0m14x15.3x1.5x
Thu, 26 May 2022RM3.9bRM2.3bRM215.3m14.2x18.1x1.7x
Sat, 23 Apr 2022RM4.0bRM2.2bRM204.5m16.6x19.6x1.8x
Mon, 21 Mar 2022RM3.7bRM2.2bRM204.5m16.1x18x1.6x
Wed, 16 Feb 2022RM3.8bRM2.1bRM187.4m16.4x20.2x1.8x
Fri, 14 Jan 2022RM3.7bRM2.1bRM187.4m15.6x19.8x1.7x
Sun, 12 Dec 2021RM3.7bRM2.1bRM187.4m15.3x19.7x1.7x
Tue, 09 Nov 2021RM3.7bRM2.0bRM166.6m20.4x22.2x1.8x
Thu, 07 Oct 2021RM3.9bRM2.0bRM166.6m20.7x23.2x1.9x
Sat, 04 Sep 2021RM4.2bRM2.0bRM166.5m21.3x25.3x2.1x
Mon, 02 Aug 2021RM4.2bRM2.0bRM166.5m19.7x25.2x2.1x
Thu, 06 May 2021RM4.3bRM2.0bRM167.4m18.2x25.5x2.2x
Price to Earnings Ratio

25.5x


Total Market Cap: RM4.3bTotal Earnings: RM167.4mTotal Revenue: RM2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 16.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Malaysian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 8.1x which is lower than its 3-year average PE of 16.5x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 50% per year over the last three years.
  • Revenues for these companies have grown 10% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market-1.10%
Healthcare-0.48%
Pharma-1.63%
Pharma-1.63%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
YSPSAH Y.S.P. Southeast Asia Holding BerhadRM2.460.4%
+RM1.4m
3.8%PE9.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AHEALTH

RM2.98

Apex Healthcare Berhad

7D

-0.7%

1Y

11.8%

YSPSAH

RM2.46

Y.S.P. Southeast Asia Holding Berhad

7D

0.4%

1Y

3.8%

DPHARMA

RM1.14

Duopharma Biotech Berhad

7D

-5.0%

1Y

-24.0%

PLABS

RM0.19

PeterLabs Holdings Berhad

7D

-2.6%

1Y

2.7%

RHONEMA

RM0.66

Rhone Ma Holdings Berhad

7D

-1.5%

1Y

-9.7%